An official website of the United States government
Use of COVID-19 Vaccines in the United States
Interim Clinical Considerations
Summary of recent changes (last updated September 6, 2024):
- Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older
- Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances
Get Email Updates
Receive email updates about this page.
Special Situations and Populations
References and Previous Updates